See also this year's filing and all EDGAR filings for this company.
PDF Report 0000785161_2012_Encompass_Health_Corp.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | Ignoring company because Assets is zero | pre-agg | {'balance_sheet': {'company_id': '0000785161', 'EntityCommonStockSharesOutstanding': 95661996, 'Assets': 0, 'AssetsCurrent': 0, 'AssetsNonCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'DepreciationDepletionAndAmortization': 0, 'Expenses': 0, 'GeneralAndAdministrativeExpense': 0, 'GoodwillImpairmentLoss': 0, 'IntangibleAssets': 0, 'LaborExpense': 0, 'Liabilities': 0, 'LiabilitiesCurrent': 0, 'LongTermLiabilities': 0, 'NetIncome': 185000000, 'OperatingCostsAndExpenses': 0, 'PropertyPlantAndEquipment': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingAndMarketingExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 1600000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_NetIncome': 185000000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000785161')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000785161')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000785161, Encompass Health Corp
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 479,400,000 |
1 | AssetsNonCurrent | 99,300,000 |
2 | AssetsCurrent | 391,000,000 |
3 | PropertyPlantAndEquipment | 664,400,000 |
4 | remainder_Assets | 637,100,000 |
5 | LongTermLiabilities | 1,369,000,000 |
6 | LiabilitiesCurrent | 313,200,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 110,500,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 386,800,000 |
13 | DepreciationDepletionAndAmortization | 78,800,000 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 0 |
16 | remainder_Expenses | 1,220,900,000 |
17 | remainder_Revenues | 0 |
18 | remainder_NetIncome | 2,051,600,000 |
19 | remainder_ComprehensiveNetIncome | -46,600,000 |
yvar | yval | |
---|---|---|
0 | Assets | 2,271,200,000 |
1 | Liabilities | 1,682,200,000 |
2 | Expenses | 1,797,000,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 589,000,000 |
5 | NetIncome | 254,600,000 |
6 | ComprehensiveNetIncome | 208,000,000 |
7 | BaseVar | 3,924,300,000 |
8 | EconomicCapitalRatio | 0.934 |